Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5419]
News [12581]
Articles [170]
Editorials [5]
Conferences [246]
elearning [17]
Opinion: Premature regulatory approval by the FDA
Dr Bishal Gyawali - Queen's University, Kingston, Canada
Opinion: Premature regulatory approval by the FDA ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
13 Dec 2022
Polatuzumab vedotin combined with R-ICE as second-line therapy gives favourable...
Dr Matthew Matasar - Rutgers Cancer Institute, New Brunswick, USA
Polatuzumab vedotin combined with R-ICE as second-line therapy gives favourable results against R/R diffuse large B-cell lymphoma ( Dr Matthew Matasar - Rutgers Cancer Institute, New Brunswick, USA )
12 Dec 2022
Mosunetuzumab monotherapy demonstrates durable efficacy with a manageable...
Dr Matthew Matasar - Rutgers Cancer Institute, New Brunswick, USA
Mosunetuzumab monotherapy demonstrates durable efficacy with a manageable safety profile in R/R follicular lymphoma ( Dr Matthew Matasar - Rutgers Cancer Institute, New Brunswick, USA )
12 Dec 2022
Addition of platinum to standard neoadjuvant chemotherapy improves EFS in...
Dr Sudeep Gupta - Tata Memorial Centre, Mumbai, India
Addition of platinum to standard neoadjuvant chemotherapy improves EFS in patients with TNMBC ( Dr Sudeep Gupta - Tata Memorial Centre, Mumbai, India )
12 Dec 2022
Teclistamab in combination with subcutaneous daratumumab and lenalidomide shows...
Dr Emma Searle - University of Manchester, Manchester, UK
Teclistamab in combination with subcutaneous daratumumab and lenalidomide shows promising results in patients with multiple myeloma ( Dr Emma Searle - University of Manchester, Manchester, UK )
12 Dec 2022
Treatment decision guided by CTC count may improve long-term outcomes for mBC
Prof Jean-Yves Pierga - Institut Curie, Paris, France
Treatment decision guided by CTC count may improve long-term outcomes for mBC ( Prof Jean-Yves Pierga - Institut Curie, Paris, France )
9 Dec 2022
The future of precision oncology
Dr Benedikt Westphalen - Comprehensive Cancer Center München, Munich, Germany
The future of precision oncology ( Dr Benedikt Westphalen - Comprehensive Cancer Center München, Munich, Germany )
7 Dec 2022
The concept of pan-tumour therapeutics
Dr Benedikt Westphalen - Comprehensive Cancer Center München, Munich, Germany
The concept of pan-tumour therapeutics ( Dr Benedikt Westphalen - Comprehensive Cancer Center München, Munich, Germany )
7 Dec 2022
Access to Oncology Medicines Coalition - The Medicines Patent Pool
Charles Gore - Medicines Patent Pool, Geneva, Switzerland
Access to Oncology Medicines Coalition - The Medicines Patent Pool ( Charles Gore - Medicines Patent Pool, Geneva, Switzerland )
1 Dec 2022
Challenges and opportunities of integrative oncology as an effective tool to...
Dr Partha Basu - International Agency for Research on Cancer, Lyon, France
Challenges and opportunities of integrative oncology as an effective tool to enhance cancer prevention and treatment in LMICs. ( Dr Partha Basu - International Agency for Research on Cancer, Lyon, France )
23 Nov 2022
Is Latin America ready to overcome the challenges of implementing Precision...
Dr Daniel Campos - Latin American & Caribbean Society of Medical Oncology...
Is Latin America ready to overcome the challenges of implementing Precision Medicine? ( Dr Daniel Campos - Latin American & Caribbean Society of Medical Oncology, Buenos Aires, Argentina )
23 Nov 2022
Systemic anti-cancer performance matrix
Prof Richard Sullivan, Kari Leung and Megan McLeod
Systemic anti-cancer performance matrix ( Prof Richard Sullivan, Kari Leung and Megan McLeod )
23 Nov 2022

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation